United Capital Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $55.5M | Buy |
255,395
+2,802
| +1% | +$622K | 0.34% | 56 |
|
|
2025
Q4 | $57.7M | Buy |
252,593
+9,243
| +4% | +$2.11M | 0.35% | 57 |
|
|
2025
Q3 | $56.3M | Buy |
243,350
+47,458
| +24% | +$9.66M | 0.4% | 50 |
|
|
2025
Q2 | $36.4M | Sell |
195,892
-2,244
| -1% | -$417K | 0.29% | 74 |
|
|
2025
Q1 | $41.5M | Sell |
198,136
-446
| -0.2% | -$86.7K | 0.36% | 61 |
|
|
2024
Q4 | $35.3M | Sell |
198,582
-5,199
| -3% | -$956K | 0.3% | 74 |
|
|
2024
Q3 | $40.2M | Sell |
203,781
-601
| -0.3% | -$112K | 0.33% | 67 |
|
|
2024
Q2 | $35.1M | Sell |
204,382
-56,592
| -22% | -$9.37M | 0.3% | 68 |
|
|
2024
Q1 | $47.5M | Sell |
260,974
-21,222
| -8% | -$3.66M | 0.39% | 58 |
|
|
2023
Q4 | $43.7M | Sell |
282,196
-108,965
| -28% | -$15.9M | 0.36% | 62 |
|
|
2023
Q3 | $58.3M | Sell |
391,161
-32,642
| -8% | -$4.79M | 0.38% | 54 |
|
|
2023
Q2 | $57.1M | Sell |
423,803
-36,971
| -8% | -$5.42M | 0.31% | 68 |
|
|
2023
Q1 | $73.4M | Sell |
460,774
-19,986
| -4% | -$3.06M | 0.41% | 46 |
|
|
2022
Q4 | $77.7M | Sell |
480,760
-23,233
| -5% | -$3.56M | 0.44% | 45 |
|
|
2022
Q3 | $67.6M | Sell |
503,993
-58,990
| -10% | -$8.46M | 0.4% | 47 |
|
|
2022
Q2 | $86.2M | Buy |
562,983
+55,809
| +11% | +$8.53M | 0.47% | 37 |
|
|
2022
Q1 | $82.2M | Sell |
507,174
-260
| -0.1% | -$37.8K | 0.4% | 46 |
|
|
2021
Q4 | $68.7M | Sell |
507,434
-5,022
| -1% | -$593K | 0.32% | 63 |
|
|
2021
Q3 | $55.3M | Sell |
512,456
-9,723
| -2% | -$1.11M | 0.28% | 73 |
|
|
2021
Q2 | $58.8M | Buy |
522,179
+13,104
| +3% | +$1.48M | 0.3% | 72 |
|
|
2021
Q1 | $55.1M | Sell |
509,075
-16,534
| -3% | -$1.77M | 0.3% | 71 |
|
|
2020
Q4 | $56.3M | Buy |
525,609
+18,804
| +4% | +$1.81M | 0.34% | 65 |
|
|
2020
Q3 | $44.4M | Sell |
506,805
-2,833
| -0.6% | -$267K | 0.29% | 78 |
|
|
2020
Q2 | $50M | Sell |
509,638
-3,855
| -0.8% | -$339K | 0.36% | 64 |
|
|
2020
Q1 | $39.1M | Sell |
513,493
-17,597
| -3% | -$1.5M | 0.32% | 69 |
|
|
2019
Q4 | $47M | Buy |
531,090
+18,249
| +4% | +$1.52M | 0.3% | 71 |
|
|
2019
Q3 | $38.8M | Buy |
512,841
+68,622
| +15% | +$4.7M | 0.27% | 88 |
|
|
2019
Q2 | $32.3M | Buy |
444,219
+17,760
| +4% | +$1.4M | 0.21% | 107 |
|
|
2019
Q1 | $34.4M | Sell |
426,459
-8,967
| -2% | -$734K | 0.24% | 98 |
|
|
2018
Q4 | $40.1M | Buy |
435,426
+7,678
| +2% | +$675K | 0.32% | 71 |
|
|
2018
Q3 | $40.5M | Sell |
427,748
-5,371
| -1% | -$509K | 0.28% | 74 |
|
|
2018
Q2 | $40.1M | Sell |
433,119
-1,937
| -0.4% | -$189K | 0.3% | 69 |
|
|
2018
Q1 | $41.2M | Sell |
435,056
-10,531
| -2% | -$1.16M | 0.31% | 69 |
|
|
2017
Q4 | $43.6M | Buy |
445,587
+3,163
| +0.7% | +$298K | 0.34% | 64 |
|
|
2017
Q3 | $39.3M | Buy |
442,424
+3,540
| +0.8% | +$269K | 0.33% | 60 |
|
|
2017
Q2 | $31.8M | Sell |
438,884
-6,124
| -1% | -$412K | 0.28% | 81 |
|
|
2017
Q1 | $29M | Buy |
445,008
+645
| +0.1% | +$40.6K | 0.27% | 82 |
|
|
2016
Q4 | $27.8M | Sell |
444,363
-5,085
| -1% | -$310K | 0.27% | 78 |
|
|
2016
Q3 | $28.3M | Sell |
449,448
-12,455
| -3% | -$806K | 0.28% | 76 |
|
|
2016
Q2 | $28.6M | Buy |
461,903
+6,842
| +2% | +$417K | 0.29% | 65 |
|
|
2016
Q1 | $26M | Sell |
455,061
-332
| -0.1% | -$18.5K | 0.29% | 70 |
|
|
2015
Q4 | $27M | Buy |
455,393
+182,375
| +67% | +$10.5M | 0.31% | 56 |
|
|
2015
Q3 | $14.9M | Sell |
273,018
-5,075
| -2% | -$330K | 0.18% | 117 |
|
|
2015
Q2 | $18.7M | Buy |
278,093
+2,084
| +0.8% | +$136K | 0.22% | 107 |
|
|
2015
Q1 | $17.8M | Buy |
276,009
+12,040
| +5% | +$727K | 0.22% | 114 |
|
|
2014
Q4 | $17.3M | Buy |
263,969
+86,519
| +49% | +$5.45M | 0.26% | 97 |
|
|
2014
Q3 | $10.3M | Sell |
177,450
-10,201
| -5% | -$566K | 0.18% | 143 |
|
|
2014
Q2 | $10.6M | Buy |
187,651
+39,965
| +27% | +$2.1M | 0.2% | 138 |
|
|
2014
Q1 | $7.59M | Buy |
147,686
+29,870
| +25% | +$1.51M | 0.16% | 145 |
|
|
2013
Q4 | $6.22M | Sell |
117,816
-62,052
| -34% | -$3.05M | 0.21% | 124 |
|
|
2013
Q3 | $8.04M | Buy |
179,868
+9,031
| +5% | +$400K | 0.26% | 88 |
|
|
2013
Q2 | $7.06M | Buy |
+170,837
| New | +$7.47M | 0.19% | 138 |
|
Other funds holding ABBV
VCM
VPM
United Capital Financial Advisors's ABBV Position: Q1 2026 in Review
United Capital Financial Advisors increased its AbbVie (ABBV) stake by 1.1% in Q1 2026, buying an estimated $622K and bringing the position to 255,395 shares worth $55.5M. The position accounts for 0.34% of the portfolio, ranked #56.
United Capital Financial Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $86.2M in Q2 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- United Capital Financial Advisors held 255,395 shares of AbbVie worth $55.5M as of Q1 2026.
- United Capital Financial Advisors bought 2,802 AbbVie shares in Q1 2026, an estimated $622K.
- AbbVie made up 0.34% of United Capital Financial Advisors's portfolio in Q1 2026, its #56 holding.
- United Capital Financial Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- United Capital Financial Advisors's AbbVie position peaked at $86.2M in Q2 2022.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.